Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
www.cnbc.com Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
3
comments
Is it common for a medicine to be 100% effective? That seems weird to me.